candid v3 tablets 200
glenmark pharmaceuticals limited, india - clotrimazole - tablets - 200
olympus urf-v3 uretero-reno videoscope
olympus singapore pte ltd - gastroenterology & urology - this instrument has been designed to be used with an olympus video system center, light source, documentation equipment, monitor, endotherapy accessories, and other ancillary equipment for endoscopic diagnosis and treatment within the ureter and kidney through a percutaneous route and transurethrally.
brilliantdye terminator (v3.1) cycle sequencing kit
inqaba biotec east africa limited, tanzania - laboratory reagent -
nature's care super cranberry 15000 (v3)
nature's care manufacture pty limited - calcium ascorbate,vaccinium macrocarpon -
donepezil-drla donepezil hydrochloride (as monohydrate) 10mg tablet blister pack
dr reddys laboratories australia pty ltd - donepezil hydrochloride monohydrate, quantity: 10.43 mg (equivalent: donepezil hydrochloride, qty 10 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; hyprolose; lactose monohydrate; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 400 - treatment of mild, moderate and severe alzheimer's disease.
donepezil-drla donepezil hydrochloride (as monohydrate) 5mg tablet blister pack
dr reddys laboratories australia pty ltd - donepezil hydrochloride monohydrate -
cataflam 50 mg
novartis israel ltd - diclofenac as potassium - tablets - diclofenac as potassium 50 mg - diclofenac - diclofenac - management of pain and primary dysmenorrhea, when prompt pain relief is desired.
nevanac
novartis israel ltd - nepafenac - ophthalmic suspension - nepafenac 0.1 % - nepafenac - nepafenac - prevention and treatment of postoperative pain and inflammation associated with cataract surgery and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
tabrecta 150 mg
novartis israel ltd - capmatinib as dihydrochloride monohydrate - film coated tablets - capmatinib as dihydrochloride monohydrate 150 mg - capmatinib - tabrecta is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (nsclc) whose tumors have a mutation that leads to mesenchymal-epithelial transition (met) exon 14 skipping as detected by an approved test.
tabrecta 200 mg
novartis israel ltd - capmatinib as dihydrochloride monohydrate - film coated tablets - capmatinib as dihydrochloride monohydrate 200 mg - capmatinib - tabrecta is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (nsclc) whose tumors have a mutation that leads to mesenchymal-epithelial transition (met) exon 14 skipping as detected by an approved test.